SGNT Key Stats
- SAGENT PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote... Jun 14
- This Metric Says You're Smart to Own Sagent Pharmaceuticals Fool Jun 14
- Sagent Pharma (SGNT) Expands Recall Street Insider Jun 13
- InPlay: Sagent Pharma expands a nationwide voluntary recall to all lots of Vecur... Jun 13
- Sagent Pharmaceuticals Expands a Nationwide Voluntary Recall to All Lots of Vecu... Jun 13
- Sagent Recalls Anesthesia Drug Dosages Fool Jun 9
- 4 Healthcare Stock Stories As a Weekend Investment Prescription Jun 7
- Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Three Lots of ... Jun 7
- Sagent Pharmaceuticals Stays On Its Margin Hot Streak Fool Jun 6
- China Biotech In Review: Sagent Buys Out China JV Partner For $25 Million May 12
SGNT Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Sagent Pharmaceuticals is up 5.29% over the last year vs S&P 500 Total Return up 23.89%, Acura Pharmaceuticals down 34.41%, and ImmunoBiotics down 44.00%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for SGNT
Pro Report PDF for SGNT
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download SGNT Pro Report PDF
Pro Strategies Featuring SGNT
Did Sagent Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.